Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.36 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.34 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.34 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.34 |
| ▸ | PTGIR | P43119 | 8/20 | 0.34 |
| ▸ | PTGDR | Q13258 | 4/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2966870 | 1.00 | — | — | |
| SCHEMBL3677140 | 0.90 | LMNA (0.52) | LMNASLC1A3SLC1A2SLC1A1PARP15 | |
| SCHEMBL2590590 | 0.90 | — | — | |
| SCHEMBL11751290 | 0.88 | LMNA (0.55) | LMNASLC1A3SLC1A2SLC1A1PARP15 | |
| SCHEMBL2937173 | 0.88 | LMNA (0.55) | LMNASLC1A3SLC1A2SLC1A1PARP15 | |
| SCHEMBL20656899 | 0.82 | SIGMAR1 (0.42) | ACHE | |
| SCHEMBL20656958 | 0.81 | HTR4 (0.44) | BCHEACHECHRM3 | |
| SCHEMBL29063243 | 0.81 | SCN9A (0.36) | LMNASLC1A3SLC1A2SLC1A1 | |
| SCHEMBL30937187 | 0.81 | LMNA (0.33) | LMNASLC1A3SLC1A2SLC1A1 | |
| SCHEMBL9723991 | 0.81 | PKM (0.43) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | claimed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | disclosed |
| EP-2651917-A1 | DIMERIC IAP INHIBITORS | Novartis AG (CH) | 2013-10-23 | — | — | EP | disclosed |
| US-20130266590-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2013-10-10 | — | — | US | disclosed |
| US-8445440-B2 | Dimeric IAP inhibitors | NOVARTIS AG (CH) | 2013-05-21 | — | — | US | disclosed |
| EP-2539333-A1 | DIMERIC IAP INHIBITORS | Novartis AG (CH) | 2013-01-02 | — | — | EP | disclosed |
| WO-2012080260-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2012-06-21 | — | — | WO | disclosed |
| WO-2011104266-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2011-09-01 | — | — | WO | disclosed |
| US-20110206690-A1 | DIMERIC IAP INHIBITORS | NOVARTIS AG (CH) | 2011-08-25 | — | — | US | disclosed |
| EP-1071662-B1 | PEROXIDES, THEIR PREPARATION PROCESS AND USE | AKZO NOBEL NV (NL) | 2004-08-04 | — | — | EP | disclosed |
| US-6770774-B2 | USING A PEROXY COMPOUND AS CURING AGENT, POLYMERIZATION CATALYST | AKZO NOBEL N.V. (NL) | 2004-08-03 | — | — | US | disclosed |
| US-20030073861-A1 | Using a peroxy compound as curing agent, polymerization catalyst | VAN DE BOVENKAMP-BOUWMAN ANNA (NL) | 2003-04-17 | — | — | US | disclosed |
| US-6482970-B1 | Peroxides, their preparation process and use | AKZO NOBEL NV (NL) | 2002-11-19 | — | — | US | disclosed |
| US-5426190-A | Preparation of N-(organocarbonyloxy)-succinimide derivatives of N-hydroxysuccinimide | PPG INDUSTRIES, INC. (US) | 1995-06-20 | — | — | US | disclosed |
| EP-0078885-B1 | DI(ACYLPEROXY)-1,4-CYCLOHEXANE DIMETHANOL-BIS-CARBONATES AND METHODS OF USE | U.S. Peroxygen Company (US) | 1986-01-29 | — | — | EP | disclosed |
| EP-0078885-A1 | Di(acylperoxy)-1,4-cyclohexane dimethanol-bis-carbonates and methods of use | U.S. Peroxygen Company (US) | 1983-05-18 | — | — | EP | disclosed |
| US-4372877-A | ADDITION POLYMERIZATION CATALYSTS, CURING AGENTS FOR UNSATURATED POLYESTERS | U.S. PEROXYGEN COMPANY (US) | 1983-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130266590-A1 | DIMERIC IAP INHIBITORS | XIAP, BIRC5, BIRC2 | LMNA 182/4885SLC1A3 4034/4885SLC1A2 4356/4885 |
| US-20110206690-A1 | DIMERIC IAP INHIBITORS | XIAP, BIRC5, BIRC2 | LMNA 198/4885SLC1A3 4126/4885SLC1A2 4283/4885 |
| US-20030073861-A1 | Using a peroxy compound as curing agent, polymerization catalyst | PRDX4, ACOX3, PRDX2 | LMNA 2260/4885SLC1A3 3909/4885SLC1A2 4758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.